Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Sherman Oaks, California Clinical Trials

A listing of Sherman Oaks, California clinical trials actively recruiting patient volunteers.

RESULTS

Found (9) clinical trials

Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP Services

Culturally appropriate advertisements (designed specifically for the study population and advertisement method) for promoting HIV testing and PrEP uptake will be created by the study team. These advertisements will be placed on social media sites (Facebook, Instagram, Twitter), informational sites (Google, Bing, Yahoo) and dating apps (Grindr, Hornet, Jack'd) in ...

Phase N/A

5.92 miles

Learn More »

Radicava (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)

Treatment will be prescribed by HCPs in accordance with their clinical judgement and the prescribing information for Edaravone. The decision to prescribe Edaravone to the participants should be made separately from the decision to enroll then in the study. There will be no randomized assignments to treatment and no restrictions ...

Phase N/A

5.92 miles

Learn More »

Micra AV Transcatheter Pacing System Post-Approval Registry

The Micra AV Registry is a global, prospective, observational, multi-site registry. Patients enrolled in the Micra AV Registry will be prospectively followed for a minimum of 3 years post-implant or until registry closure, patient death, patient exit from the registry (i.e., withdrawal of consent). Enrolled patients will have scheduled follow-up ...

Phase N/A

6.9 miles

Learn More »

Alfapump System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study)

The POSEIDON Study is a multicenter, single arm within subject crossover design pivotal trial conducted in patients diagnosed with refractory or recurrent ascites due to liver cirrhosis who meet inclusion/exclusion criteria. The study will enroll up to 60 pivotal cohort patients with refractory or recurrent ascites at up to 15 ...

Phase N/A

6.9 miles

Learn More »

MitraClip EXPAND G4 Study

This is a post-market, multi-center, single-arm, prospective study to assess the safety and performance of the next generation MitraClip G4 System. The current protocol describes the design of this post-market study. Up to 100 post-market, consecutive, consented, patients treated with a MitraClip G4 device will be included for analysis into ...

Phase N/A

6.9 miles

Learn More »

Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation

850 million individuals suffer from chronic kidney disease (CKD), while diabetes, cancer, and HIV/AIDS affect 422, 42, and 37 million individuals, respectively. End stage renal disease (ESRD) hence places a heavy burden on health systems worldwide. Linked to that, the kidney-disease-associated mortality rate worldwide has risen over the past decade, ...

Phase N/A

6.9 miles

Learn More »

Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies

Subjects in the intervention arm will be provided with life expectancy estimates specific to their age and health status. Life expectancy estimates for prostate and kidney cancer patients will be estimated by age and Charlson comorbidity score cutoffs, and life expectancy for bladder cancer patients will be determined using definitions ...

Phase N/A

6.9 miles

Learn More »

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Long-term study to assess the safety and efficacy of nemolizumab in subjects with moderate-to-severe AD

Phase

7.21 miles

Learn More »

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines

This is a Phase 2, multicenter, open-label, single-arm study to evaluate the efficacy and safety of DaxibotulinumtoxinA for injection (DAXI for injection) in the treatment of Glabellar Lines (GL), Dynamic Forehead Lines (FHL), and Lateral Canthal Lines(LCL)

Phase

8.53 miles

Learn More »